Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Dow
Fuji
Mallinckrodt
Merck
Cerilliant
Baxter
Healthtrust
Teva

Generated: October 21, 2018

DrugPatentWatch Database Preview

Alcon Pharms Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for ALCON PHARMS LTD, and when can generic versions of ALCON PHARMS LTD drugs launch?

ALCON PHARMS LTD has fourteen approved drugs.

There is one US patent protecting ALCON PHARMS LTD drugs.

Summary for Alcon Pharms Ltd
US Patents:1
Tradenames:13
Ingredients:13
NDAs:14

Drugs and US Patents for Alcon Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Pharms Ltd GENTAMICIN SULFATE gentamicin sulfate SOLUTION/DROPS;OPHTHALMIC 062523-001 Nov 25, 1985 DISCN No No ➤ Sign Up ➤ Sign Up
Alcon Pharms Ltd CYCLOPENTOLATE HYDROCHLORIDE cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 089162-001 Jan 24, 1991 DISCN No No ➤ Sign Up ➤ Sign Up
Alcon Pharms Ltd PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION/DROPS;OPHTHALMIC 081043-001 Oct 24, 1991 DISCN No No ➤ Sign Up ➤ Sign Up
Alcon Pharms Ltd PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION/DROPS;OPHTHALMIC 081044-001 Oct 24, 1991 DISCN No No ➤ Sign Up ➤ Sign Up
Alcon Pharms Ltd BETADINE povidone-iodine SOLUTION/DROPS;OPHTHALMIC 018634-001 Dec 17, 1986 RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Alcon Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon Pharms Ltd TRAVATAN travoprost SOLUTION/DROPS;OPHTHALMIC 021257-001 Mar 16, 2001 6,011,062 ➤ Sign Up
Alcon Pharms Ltd TRAVATAN travoprost SOLUTION/DROPS;OPHTHALMIC 021257-001 Mar 16, 2001 5,510,383 ➤ Sign Up
Alcon Pharms Ltd BETAXON levobetaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 021114-001 Feb 23, 2000 4,911,920*PED ➤ Sign Up
Alcon Pharms Ltd BETAXON levobetaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 021114-001 Feb 23, 2000 5,540,918*PED ➤ Sign Up
Alcon Pharms Ltd TRAVATAN travoprost SOLUTION/DROPS;OPHTHALMIC 021257-001 Mar 16, 2001 5,849,792 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ALCON PHARMS LTD drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Ophthalmic Solution 0.00% ➤ Subscribe 2008-11-28

Supplementary Protection Certificates for Alcon Pharms Ltd Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2014029 Lithuania ➤ Sign Up PRODUCT NAME: TRAVOPROSTUM; REGISTRATION NO/DATE: EU/1/01/199/001 - EU/1/01/199/002 20011129
00671 Netherlands ➤ Sign Up PRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EG EU/1/01/199/001-002 20011128
0722 Netherlands ➤ Sign Up PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720
2008006 Lithuania ➤ Sign Up PRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712
C/GB12/047 United Kingdom ➤ Sign Up PRODUCT NAME: DEXAMETHASONE; REGISTERED: UK EU/1/10/638/001 20100727
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cipla
QuintilesIMS
Covington
Farmers Insurance
Daiichi Sankyo
Federal Trade Commission
UBS
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.